HCA Healthcare Exceeds National Average for Patient Safety Grades
HCA Healthcare announced that 81% of its hospitals earned an “A” or “B” in the fall 2022 Leapfrog Hospital Safety Grade, significantly surpassing the national average of 57%. Notably, 82 hospitals received an “A,” with Rose Medical Center and St. David’s Medical Center achieving a “Straight A” designation since 2012. The Leapfrog Group evaluates hospitals based on patient safety measures. HCA emphasizes a culture of safety, aided by initiatives like the REDUCE MRSA study showing a 44% reduction in bloodstream infections.
- 81% of HCA hospitals earned an 'A' or 'B' in the Leapfrog Hospital Safety Grade, compared to 57% national average.
- 82 hospitals received an 'A' grade, indicating strong patient safety performance.
- HCA's culture of safety is reinforced by numerous initiatives aimed at improving patient outcomes.
- None.
More than
Twice a year,
“We are proud of this accomplishment and of the culture of safety
Eighty-two
-
Establishing a
Patient Safety Organization (PSO) to improve patient safety and the quality of healthcare delivery by partnering with colleagues atHCA Healthcare facilities to build systems, refine processes and foster a culture of safety. -
Developing evidence-based perinatal protocols through the company’s longstanding partnership with
March of Dimes , such as prohibiting elective delivery prior to 39 weeks to help babies have a healthy start to life. This best practice has now been adopted worldwide as a standard of care.HCA Healthcare has also worked to identify and develop solutions for top perinatal safety risks including preeclampsia, deep vein thrombosis (DVT) and pulmonary embolism (PE) in C-Section deliveries, and post-partum hemorrhage. -
Hosting the REDUCE MRSA study, with nearly 75,000 patients across 43
HCA Healthcare hospitals, which found that using antimicrobial soap and ointment to decolonize all ICU patients reduced bloodstream infections by44% and MRSA by37% . TheCDC has since adopted this practice. -
Conducting the ABATE Infection Trial at 53
HCA Healthcare hospitals with 330,000 patients in 194 non-ICU units, which found an infection control technique achieved a31% reduction in bloodstream infections and nearly a40% reduction in antibiotic-resistant bacteria among non-ICU patients with central line catheters and lumbar drains. - Developing the Sepsis Prediction and Optimization of Therapy (SPOT) tool, a system to help clinicians more quickly identify patients with sepsis.
-
Building upon the capabilities of SPOT technology to develop the Next-gen Analytics for Treatment and Efficiency (NATE) platform during the COVID-19 pandemic. NATE brings analytic insights to assist clinicians in applying the appropriate clinical protocol for mechanically ventilated patients. This ability helped to decrease length of stay and increase survival in
HCA Healthcare facilities by28% . - Reducing HCA Healthcare’s average door-to-needle-time to 34 minutes, faster than the national standard for stroke care.
About
All references to “Company,” “HCA” and “HCA Healthcare” as used throughout this document refer to
View source version on businesswire.com: https://www.businesswire.com/news/home/20221206005222/en/
INVESTOR CONTACT:
615-344-2688
MEDIA CONTACT:
615-344-1851
Source:
FAQ
What percentage of HCA hospitals received high safety grades in 2022?
How does HCA Healthcare's safety performance compare nationally?